abstract: Oocytes become enclosed in primordial follicles during fetal life and remain dormant there until activation followed by growth and meiotic resumption. Current knowledge about the molecular pathways involved in oogenesis is incomplete. This study identifies the specific transcriptome of the human oocyte in the quiescent state and at the pinnacle of maturity at ovulation. In silico bioinformatic comparisons were made between the transcriptome of human oocytes from dormant primordial follicles and that of human metaphase II (MII) oocytes and granulosa cells and unique gene expression profiles were identified as well as functional and pathway enrichments associated with the oocytes from the two developmental hallmarks. A total of 729 genes were highly enriched in oocytes from primodial follicles and 1456 genes were highly enriched in MII oocytes (.10-fold, P , 0.001) representing functional categories such as cell cycle regulation, DNA protection and epigenetics, with representative genes validated by qPCR analysis. Dominating canonical pathways in the oocytes from primordial follicles were androgen, estrogen receptor, glucocorticoid receptor and PI3K/AKT signaling (P , 0.001). In the MII, mitotic roles of polo-like kinases, estrogen receptor, JAK/Stat signaling (P , 0.001) and the ERK/MAPK (P , 0.01) signaling were enriched. Some of the highly differentially expressed genes were completely new in human reproduction (CDR1, TLC1A, UHRF2) while other genes [ABO, FOLR1 (folate receptor), CHRNA3 (nicotine receptor)] may relate to clinical observations as diverse as premature ovarian failure, folic acid deficiency and smoking affecting female fertility. The in silico analysis identified novel reproduction-associated genes and highlighted molecular mechanisms and pathways associated with the unique functions of the human oocyte in its two extremes during folliculogenesis. The data provides a fundamental basis for future functional studies in regulation of human oogenesis.
Introduction
The human oocyte is a unique cell that differs from all other cells in the human body. First of all, it is the cell that possesses the capacity to form a new offspring and secure continuation of the gene pool and is of utmost importance from an evolutionary point of view. Further, the length of the oocyte cell cycle is extraordinarily long, potentially up to five decades under the condition that the oocyte becomes surrounded by somatic cells and forms the primordial follicle during fetal life. The follicle constitutes the functional unit of the ovaries and once primordial follicles becomes activated, the follicle will either develop to full maturity during approximately half a year containing a mature oocyte capable of sustaining fertilization and embryo development or undergo atresia at some point during growth and development.
The mechanisms that induce growth and maturation of the follicles are poorly understood, though it has been demonstrated that the oocyte itself plays a crucial role in the complex bidirectional interaction between the oocytes and granulosa cells (Eppig, 2001; Gilchrist et al., 2008) . During follicular development, the supporting granulosa cells proliferate and differentiate from 30 pregranulosa cells (Westergaard et al., 2007) to around 60 million mural granulosa cells in the human fully mature follicle (McNatty et al., 1979) and support ovulation of an oocyte embedded in cumulus cells. In this process the oocyte grows in diameter from around 30 mm in the primordial follicle (Westergaard et al., 2007) to 110 mm in the preovulatory follicle. The multiple processes that regulate folliculogenesis are very complex and far from being fully understood, especially in humans. One possible way of further elucidating the processes involved in growth and development of human oocytes and the mechanisms that govern the cell cycle dormant stage to the development of metaphase II (MII) oocytes (the fully mature oocytes), is to compare the whole transcriptomes of oocytes from primordial follicles with those of MII oocytes and granulosa cells (Grondahl et al., 2010; Markholt et al., 2012) . In addition, comparison between the transcriptomes of the two oocyte stages will provide data on the transcripts stockpiled in the MII oocyte during oogenesis. Thus, the aim of the present study was by in silico microarray analysis to describe the unique transcriptomes associated with the oocytes from two developmental hallmarks. We identified commonly expressed genes as well as genes specific to each stage and have for the first time described the unique biological network required during the two stages of oocyte maturation in human female reproduction.
Materials and Methods

Gene expression array data analysis
The microarray data used in this study is presented in the following papers: Primordial oocytes (Markholt et al., 2012) MII oocytes (Grondahl et al., 2010) and granulosa cell  Table I ). All studies were approved by the Danish Scientific Ethical Committee (Danish Scientific Ethical Committee Approval Number: KF 299017 and J/KF/01/170/99 and KF 299017, respectively). Participants provided their written consent to participate in this study. On behalf of the minors/child participants, written consents to participate in this study was obtained from parents. The ethics committees approved these consent procedures. The GeneChip Affymetrix HG_U133 2.0 probe array containing 54 675 probe sets (including affymetrix control probe sets n ¼ 62) was used in the studies.
A total of 33 samples were analyzed. Three oocyte samples from primordial follicle [representing pools of laser capture microdissected 10 mm thick sections of (i) 620 oocytes from a 21-year-old woman, (ii) 332 oocytes and (iii) 330 oocytes from a 11-year-old girl donated in connection with a fertility preservation program]; 15 samples representing individual zona pellucida free MII oocytes and 15 samples representing mural granulosa cells from individual follicles donated from 15 women aged 27 -39 years in connection with oocyte retrieval for IVF/ICSI treatment. The 33 Cel files from the microarray analysis were imported into the Partek Genomics Suite 6.5 software package and Robust Multichip Average (RMA) normalized using quantile normalization and 'Median Polish summarization' (Bolstad et al., 2003) . The modeled log-intensity of 54 675 probe sets was used for high-level analysis selecting differentially expressed genes.
All samples are MIAME compliant and are handled according to Standard Operating Procedures in the Microarray Center. The samples were submitted to ArrayExpress at 'European Molecular Biology Laboratory' using MIAMEexpress. The experiment accession number for the oocytes of primordial follicles is E-MEXP-3454, E-MEXP-2347 for MII oocytes and E-MEXP-3641 for granulosa cells.
Differentially expressed genes
To display overall differences in expression of the three cell types primordial oocyte (n ¼ 3), MII oocyte (n ¼ 15) and mural granulosa cells (n ¼ 15), a multi-group comparison was performed using an F-test selecting the 2000 most significantly changed probe sets, corresponding to a P-value below 1.69E213 (q,4.61E212). The expression pattern of the 2000 probe sets was visualized by hierarchical clustering with average linkage of samples and genes as implemented in Qlucore Omics Explorer 2.2 software (www.glucore.com).
To identify transcripts regulated in oocytes from primordial follicle versus MII oocytes and granulosa cells, combined, and MII oocytes versus oocytes from primordial follicles, two-group comparisons were performed. Differentially expressed genes were defined as having more than 10-fold up-or downregulation and show a significance level of P , 10 24 (corresponding to a False Discovery Rate below 6.0 × 1E24) in a Student's t-test. In order to address the differences in female age, between patients donating oocytes from primordial follicles (11-21 years) and MII oocytes (27-39 years), the intersection between MII gene expression influenced by women's age (Grondahl et al., 2010) and the genes found to be highly enriched in MII in the present study were identified. The intersection was below 1.6% (data not shown).
Detection of expressed genes analysis
Probe sets were defined to be present if the average unlogged expression value exceeded an intensity of 100. Lists of expressed genes were generated by excluding redundant probe sets based on gene symbols. Intersections of the three gene lists were visualized in a Venn diagram and lists of selectively and overlapping transcripts were generated.
Gene function enrichment and biological networks
Biological networks of the differentially expressed genes were generated in Ingenuity pathway analysis tools from Ingenuity Systems Inc. (www. ingenuity.com). The list of differentially expressed genes was imported into Ingenuity and each gene identifier was overlaid onto a global molecular network developed from information contained in the Ingenuity Pathways Knowledge Base. Functions and networks of these genes were then generated based on their connectivity. A network score was calculated based on the hyper-geometric distribution and calculated with the right-tailed Fisher's exact test. The score is the negative log of this P-value. The score takes into account the number of network eligible molecules in the network and its size, as well as the total number of network eligible molecules analyzed and the total number of molecules in the knowledge base that could potentially be included in the network. 
Validation of microarray results by quantitative RT-PCR
Validation of selected genes was performed by qPCR. Samples of independent pools of oocytes from primordial follicles and MII oocytes were collected from patients equivalent to those previously described (Grondahl et al., 2010; Markholt et al., 2012) . Briefly, MII oocytes were donated by women (27-32 years) undergoing controlled ovarian stimulation followed by oocyte retrieval for ICSI with male indication. Primordial follicles were donated in connection with an ovarian cryo-preservation program (11 and 21 years). Total RNA was isolated from the microdissected oocytes from the primordial follicle on the Laser capture microdissection caps using a RNA extraction/isolation kit (KIT0310-NS Arcturus Paradise Plus qrt PCR kit, Molecular Devices, Sunnyvale, CA, USA), as described (Markholt et al., 2012) and total RNA was extracted from MII oocytes using the PicoPure w RNA Isolation Kit (MDS, Inc., Ontario, Canada) as described (Grondahl et al., 2010) , according to the manufacture's recommendations. In this study, total RNA (25 ng) from primordial and MII oocytes, respectively, was used as input to an RNA amplification step using the WT-Ovation TM PicoSL WTA System A (cat 3312, NuGEN Technologies, Inc., CA, USA) including both oligo d(T) and random hexamers for cDNA amplifications, and 100 ng cDNA was used in each SYBR green (Applied Biosciences) qPCR reaction, as described (Markholt et al., 2012) . Primers were designed using an exon-spanning approach from Pearl Primer software (Marshall, 2004) and the NCBI Primer BLAST, and all primers were submitted to the primer BLAST search at NCBI to verify specificity; using Brilliant w SYBR Green Master Mix (Stratagene). PCR was 
) using Microsoft Excel. For each comparison normalized to HPRT1, an unpaired t-test with Welch's correction was carried out (Prism6) for the qPCR data to evaluate the significant difference P-values.
Results
Novel gene expression profiling at the onset and end of folliculogenesis Three pools of primordial oocytes (Markholt et al., 2012) , 15 MII oocytes (Grondahl et al., 2010) and 15 pools of mural granulosa samples (Grondahl et al., 2010) were expression profiled using the same Human Genome microarray platform. The three sample groups were compared by detect uniquely expressed genes and differences in expression level. The lists of genes expressed in oocytes from primordial follicles, MII oocytes and the mural granulosa cells, (Supplementary data, Table SI) show that a total of 2556 unique genes (3735 probe sets) were selectively present in the oocytes from primordial follicles and not expressed in the MII oocytes nor in the somatic cell compartment as presented by a Venn diagram (Fig. 1A) . In the MII oocytes, 1387 genes were selectively expressed (1776 probe sets), whereas the granulosa cells selectively expressed 2234 genes (3049 probe sets; Fig. 1A ). Interestingly, MII oocytes and the granulosa cells have a higher number of co-expressed genes (2585) when compared with (i) oocytes from primordial follicles and MII oocytes (1335) and (ii) oocytes from primordial follicles and granulosa cells (1191) (Fig. 1A ; The gene lists representing each compartment of the Venn diagram are presented in Supplementary data, Table SII ). Among genes expressed in the oocyte-specific overlap (1335) biological categories such as 'regulation of mitosis', 'chromosome condensation' and 'Meiosis I' were enriched (P , 0.05; Supplementary data, Table SIII ).
None of the three lists of expressed genes represented the common leukocyte antigen CD45 (PTPRC, protein tyrosine phosphatase, receptor type, C), indicating no or negligible blood contamination to the samples.
Up-regulated genes in the primordial follicle
To identify transcripts that were enriched in oocytes from primordial follicles, a two-group comparison of oocytes from primordial follicles to MII oocytes and granulosa cells combined was performed. Differentially expressed genes were defined as having a 10-fold up-or downregulation and exhibit a significance level in a Student's t-test of P , 1E210 (corresponding to a False Discovery Rate below 6.0 × 1E24), resulting in 1333 unique genes (1846 probe sets) being differentially expressed. Of these, 729 unique genes (1107 probe sets) showed a higher expression in oocytes from primordial follicles (Supplementary data, Table SIVA) . From this group, high expression levels were found for genes such as the transmembrane protein with EGF-like and two follistatin-like domains 2 (TMEFF2), the folate receptor 1 (FOLR1), the oligophrenin 1 (OPHN1) and the cerebellar degeneration-related protein 1 (CDR1) in oocytes from primordial follicles (Table II) . Among the genes with high expression levels, several were found to be selectively expressed in oocytes from primordial follicles, i.e. CDR1, the glutamate-decarboxylase-like 1 (GADL1) and the Cyclin K (CCNK) and among genes with lower expression levels, genes as the meiosis-specific nuclear structure 1 (MNS1), the reelin (RELN) and the Heat shock transcription factor 3 (HSF3) were also selectively expressed in the oocyte in the (Table II) .
Up-regulated genes in the MII oocyte
The comparison between MII oocyte and the oocytes from primordial follicle transcriptomes resulted in 2228 genes (3019 probe sets) meeting the criteria of being differentially expressed. Of these 1456 genes (1780 probe sets) were up-regulated in the MII oocytes (Supplementary data, Table SIVB ). This showed that gene transcripts such as the zona pellucida glycoprotein 3 (ZP3), the developmental pluripotency associated 5 (DPPA5), the oocyte expressed protein homolog (OOEP) and other maternal-effect genes accumulate in human MII oocytes (Table III) . In addition, the T-cell leukemia/lymphoma 1A (TCL1A) (T-cell leukemia/lymphoma 1A), the B-cell translocation gene 4 (BTG4), the ubiquitin-like with PHD and ring finger domains (UHRF2), the v-mos Moloney murine sarcoma viral oncogene homolog (MOS) and the spermatogenesis associated 2 (SPATA2) transcripts represent selectively expressed top (high expression level) genes in human MII oocytes. The bone morphogenetic protein 15 (BMP15) transcript was moderately and selectively expressed, while the epidermal growth factor (EGF), its receptor (EGFR), the spermatogenesis and oogenesisspecific basic helix-loop-helix 2 (SOHLH2), the FBJ murine osteosarcoma viral oncogene homolog (FOS), the relaxin 1 (RLN1) and the aurora kinase B (AURKB) represent selectively but lower expressed genes. Examples on Bold genes are oocyte-specific genes/maternal-effect genes with moderate to high expression in both oocyte stages.
top genes meeting the criteria of being differentially expressed are the growth differentiation factor 9 (GDF9), the breast cancer anti-estrogen resistance 4 (BCAR4), the extra spindle pole bodies homolog 1/separase (ESPL1) and the proliferating cell nuclear antigen (PCNA) ( Table III) . The overall difference in expression as detected by a multi-group comparison between the three cells types is visualized in the heat map, which show the 2000 genes that best separate the expression profiles of the three different cell types (Fig. 1B) . The intense yellow cluster (top right) in the oocytes from primordial follicle samples represents a part of the genes that we found to be selectively or highly differentially expressed in the oocytes from primordial follicles.
Function enrichment analysis of differentially expressed genes
The two developmental stages of the human oocytes were illustrated by a gene set enrichment analysis using the IPA Ingenuity software (Ingenuity w Systems, www.ingenuity.com) of the 1107 probe sets enriched in the oocyte from the primordial follicle and of the 1780 probe sets enriched in the MII oocytes, respectively. The highly enriched (P , 0.001) biofunctions in the two stages of oocyte development clearly demonstrated several categories being present in both types of oocytes such as 'Cancer' and 'Genetic disorder', which were in the top of the Disease and Disorder category, as was 'Cell cycle' in the 'Molecular and Cellular Functions' category (Table IV) .
Furthermore 'Transcription' and 'RNA post-transcriptional modification' were gene categories enriched in oocytes from primordial follicles (Table IV) . The three top bio-functions represented genes such as the forkhead box N3 (FOXN39), the POU class 3 homeobox 2 (POU3F2) and the SRY (sex determining region Y)-box 5 (SOX5) in the 'Gene expression', whereas the UPF3 regulator of nonsense transcripts homolog B (UPF3B) was listed in the 'RNA Post-transcriptional Modification' group and genes such as BRCA2, the mouse double minute 2 (MDM2), the budding uninhibited by benzimidazoles 1 homolog (BUB1) and the tumor protein p63 (TP63) were filed in the 'cell cycle' (Supplementary data, Table SVA) . MII oocyte up-regulated genes represented bio-functions as 'Cell cycle', 'Cell death' and 'DNA replication, recombination and repair' and were represented by genes such as AURKB, the transforming growth factor, beta receptor III (TGFBR3) and FOS, respectively (Table IV) . In the functional annotated term referred to as 'cell division process' listed in the 'cell cycle ' function, 139 genes were listed, and of those, 26 genes were categorized as 'decreases cell division process', while 27 genes listed as 'increases the cell division process' (Supplementary data, Table SVB) .
Enriched networks and pathways
The functional analysis of the two gene sets (enriched in oocytes from primordial follicles and MII oocytes, respectively) listed 'cell cycle network' as particular enriched, which, interestingly, revealed very distinct networks ( Fig. 2A and B, respectively) . The oocytes from primordial follicles 'cell cycle network' category was highly represented by tumor suppressor genes, i.e. Familial Adenomatous Polyposis (APC), BUB1 and catenin beta 1 (CTNNB1) ( Fig. 2A) , whereas MII oocyte 'cell cycle network' showed a high representation of genes involved in cell cycle progression, i.e. cyclin B1 (CCNB1), cyclin E1 (CCNE1) and separase (ESPL1) (Fig. 2B) .
The top canonical pathways enriched in the unique transcriptome from oocytes from primordial follicles were 'androgen signaling' (P , 0.0001), 'actin cytoskeleton signaling' (P , 0.001), 'PI3K/AKT signaling' (P , 0.001; Fig. 3A ), 'glucocorticoid receptor signaling' (P , 0.001) and 'estrogen receptor signaling' (P , 0.001). In the MII oocyte transcriptome, the enriched pathways consisted of 'mitotic roles of polo-like kinases' (P , 0.001; Fig. 3B ), 'estrogen receptor signaling' (P , 0.001), 'JAK/Stat' (P , 0. 001) and the 'ERK/MAPK' (P , 0. 01) signaling.
Relative quantification of selected genes in oocytes from primordial follicles and MII oocytes
To verify the relative expression of genes represented in oocytes from primordial follicles and MII oocytes, genes were selected for qPCR The enriched bio-functions (P , 0.001) are generated in Ingenuity w from the gene lists representing genes highly (10-fold, P , 0.001) up-regulated in the two oocyte stages. The bio-functions are listed with the highest level of significance in the top and number of genes in (). Gene overlap exists between the annotated terms.
The dormant and the fully competent oocyte analysis. RNA was extracted from two independent pools of oocytes from primordial follicles and MII oocytes not used for the microarray analysis, respectively, and qPCR was performed on selected genes. Several standard housekeeping control genes were tested to find the most suitable control gene that differed the least between oocytes from primordial follicles and MII. The housekeeping control genes RPLN13A and H2AFZ showed more than 5-and 10-fold differences in Ct values between oocytes from primordial follicles and MII oocytes, respectively, and were thus excluded as good controls (data not shown). However, GAPDH, PPIA and HPRT1 all showed smaller and comparable differences in Ct values between the two oocyte stages. Since HPRT1 showed the least difference and the lowest Ct values, we used this gene as a housekeeping reference gene to normalize our qPCR data (Fig. 4) . The normalization to HPRT1 is comparable to the qPCR data normalized to both GAPDH and PPIA, respectively (Supplementary data, Fig. S1 ) and thus, combined, the qPCR data are strongly supported by three different housekeeping gene references (Ct values of control genes are described in material and methods). The selected qPCR control genes have distinct cellular functions, to avoid any co-regulations of the genes, which could bias the qPCR results by appearing falsely stable. The development-associated genes such as developmental pluripotency associated 3 (DPPA3), and ZP3 were detected in oocytes from both primordial follicles and MII oocytes (Fig. 4) . The detection of MOS and BMP15 was restricted to MII oocytes, while OOEP were predominantly expressed in MII oocytes and lowly expressed in the oocytes of the primordial follicle. FOLR1 were predominantly expressed in oocytes of the primordial follicle in contrast to a very low level in MII oocytes (Fig. 4) . All findings were in accordance with the relative expression from the array data (Tables II and III) .
Unique genetic requirements assigned to oocytes from primordial follicles, MII oocytes and granulosa cells From the transcriptome lists numerous genes are restricted to the somatic cells alone, whereas several genes are restricted to the oocyte, which can be further divided to genes represented as being present in oocytes from the beginning or the end of folliculogenesis (Fig. 5) . This reveals for the first time unique gene expressions associated with human oocytes from primordial follicles and MII oocytes and present candidates for downstream analysis to be performed from the listed genes (Tables II and III, Top canonical pathway enriched in the genes differentially expressed in the MII oocytes is the pathway denoted mitotic roles of polo-like kinases including anaphase promoting complex, several cell division cycle proteins (CDC7, CDC20, CDC25), checkpoint CHK2 and the dominant cyclin B (CCNB1) as well as of ESPL1 (separase) and PTTG1 (securin). Intensity of color represents fold change (red: higher expressed and green: lower expressed), and level of significance highlighted is meeting the criterion of being more than 10-fold differentially expressed. A key to identify node shapes is given in the figure. Lines without arrow indicate binding and full and dotted arrow lines represent direct and indirect interactions, respectively.
The dormant and the fully competent oocyte
Discussion
By comparing the transcriptome of oocytes from human primordial follicles with that of fully competent MII oocytes, the present study identified genes of specific importance at each of these unique developmental stages. These two types of oocytes represent the starting point and end of oocyte development during folliculogenesis and we assumed that genes present in both types of oocytes are of general importance, whereas genes specifically expressed in either one of the two developmental stages may be of special importance for oocytes at that particular stage. To the best of our knowledge this is the first such analysis being performed on human oocytes, which indeed are exceptional cells of the body and demonstrated a unique set of genes being active in the beginning and the end of folliculogenesis. The top functions of differentially expressed genes were similar in both types of oocytes and comprised 'cancer' and 'genetic disorders' involving, i.e. cell cycle checkpoint control and DNA damage response illustrating a broad spectrum of genes involved in processes ensuring the genetic stability of the oocyte in both developmental stages. These observations illustrate key biological events in the oocyte during folliculogenesis.
The in silico analysis may include potential batch effects since the cell populations were isolated differentially and RNA purified from paraffin-embedded (primordial) and media samples (MII and granulosa cells), respectively. The application of two different amplification protocols may contribute to bias in the data, despite linear amplification of small samples. Evaluation studies of the Ribo-SPIA protocol compared with the standard Affymetrix T7 linear amplification protocol has shown that hybridization of 2.5 mg of labeled Figure 4 Relative qPCR of selected genes in oocytes from primordial follicles and MII oocytes. Quantification of relative abundance of MOS, BMP15, FOLR1, DPPA3, ZP3 and OOEP transcripts in oocytes from primordial follicles and MII oocytes, as indicated (gray columns; oocytes from primordial follicles, blue columns; MII oocytes). All expression levels were normalized to HPRT1 and the relative expression is displayed using Excel (Microsoft). Data are presented as the mean value of triplicate measurements including standard errors. An unpaired t-test with Welch's correction P-values; P ¼ 0.0003 for MOS, P ¼ 0.0004 for BMP15, P ¼ 0.0005 for OOEP, P ¼ 0.009 for DPPA3, P ¼ 0.0012 for ZP3 and P ¼ 0.0022 for FOLR1.
cDNA using Ribo-SPIA gives similar results to arrays that were hybridized with 10 mg cRNA, based on detection call and qRT -PCR analysis (Dafforn et al., 2004; Singh et al., 2005) . Overall, the average pair-wise correlation of all signals between the two protocols was 0.73, compared with 0.99 within each protocol batch. Since it has been shown that the two protocols show considerable correlation, but also introduce some level of systemic bias, most pronounced for low expressed genes (Hu et al., 2002) , we have chosen to account for this by setting the threshold for differentially expressed genes to show a fold change 10 and P , 0.001. We tested several different control genes to validate the gene expression based on reported oocyte control genes and their optimized used for both oligo-d(T)-and random hexamers-prepared cDNA (Mamo et al., 2007; O'Connor et al., 2012) . In addition, the data were confirmed by both qRT -PCR and literature reporting both human and rodent studies, which collectively strongly support our observations.
The pool of oocytes from primordial follicles also contains oocytes from intermediate and primary follicles (Markholt et al., 2012) , although oocytes from intermediate and primary follicles are considered to be minor or negligible based on the absence of expression of BMP15 and the relative lower ZP1 expression when compared with MII, since mice studies have shown a dramatic rise in the oocyte BMP15 expression from primordial to primary follicle and a transient high expression of ZP1 in the primary follicle when compared with the MII oocyte (Pan et al., 2005) . Likewise, concerns regarding differences in female age, between patients donating oocytes from primordial follicles (11 -21 years) and MII oocytes (28 -39 years) seem to be negligible, since ,1.6% of the transcripts highly enriched in MII were reported to be influenced in MII by increasing age of the woman (Grondahl et al., 2010) . Figure 5 Expressed genes in human oocytes at the beginning and end of folliculogenesis. Expression profiling of human oocytes from primordial follicles and MII oocytes have identified several genes not previously associated with folliculogenesis, and thus, add to the current scenery of the genetic networks and pathways required during two hallmarks of oogenesis: the cell cycle dormant stage and the fully competent stage. Selected genes from the transcriptomes, both with and without previous reported functions in the oocyte, are placed according to their expression at the beginning or end of the folliculogenesis, as indicated with dotted lines, revealing genes specific to oocytes from primordial follicles (CADL1, CCNK, CDR1, PNN, TMED2, CEP63, MNS1, RELN, SMARCA2) and MII oocytes (BTG4, C-MOS, BMP15, SPATA2, AURKB, EGFR, EGF, UHRF2, ESPL1), respectively. Genes listed below red, blue and yellow arrows indicate transcripts increasing, decreasing or comparable in oocytes from primordial follicles and MII oocytes, respectively.
Cell cycle
The transcripts over-expressed in both types of oocytes revealed an enrichment of cell cycle networks, proliferation and related regulatory mechanisms. The PI3K/AKT signaling pathway being a top canonical pathway in the oocyte from the primordial follicle is in line with a suggestion that this pathway has a key role in initiation of follicle growth and hence maintenance of the oocyte pool (John et al., 2008) , as oocytes deficient in FOXO3 (substrate for AKT and inducing cell cycle arrest) and PTEN (inhibiting PI3K/AKT pathway) both result in global primordial follicle activation (John et al., 2008) . Thus, an enrichment of the PI3K/AKT signaling pathway and presence of both PTEN and FOXO3 expressed at a low to moderate level in the oocytes from the primordial follicle may confirm a constant presence of positive and negative feedback loops (John et al., 2008) . Moreover, estradiol has recently been shown to increase PTEN expression in estrogen receptor (ER) positive cells (neuronal cell line; Yang et al., 2011) and AR signaling suggested to inhibit PTEN transcription in prostate and breast cancers . Both the ER signaling pathway and androgen signaling pathway were enriched in oocytes from primordial follicles and the estrogen receptors (ERS1 and ERS2) as well as AR were present at a low level suggesting importance of these pathways in the oocytes from the primordial follicle potentially involved in the PTEN regulation and other pathways leading to the activation of growth in the primordial follicle. Testosterone has been reported to initiate follicle growth in the primate ovary (Vendola et al., 1999) and the presence of AR expressed at a low level in the human oocyte in the primordial follicle support the suggestion that androgens act directly on the oocyte (Vendola et al., 1999) .
One of the genes with the highest relative expression in oocytes from primordial follicles, in contrast to its absence in MII oocytes, was a gene located on the X chromosome encoding the protein Cerebellar Degeneration-Related protein 1 (CDR1). The function of CDR1 is unknown; however, it was identified in a subset of patients with paraneoplastic cerebellar degeneration (PCD) and cell lines derived from cancers of neuroectodermal, kidney, and lung origin (Dropcho et al., 1987) and further detected in tumor tissues from PCD patients (Furneaux et al., 1989) . It has been reported that CDR1 expression in endothelial cell culture was significantly up-regulated by estradiol in a PI3K-dependent fashion (Pedram et al., 2002) and, thus, it will be interesting to evaluate whether the high CDR1 expression in the oocyte from the primordial follicle is linked to the enriched gene activity of PI3K/AKT and ER signaling.
Interestingly, the nicotine receptor cholinergic receptor, nicotinic, alpha 3 (CHRNA3) was represented in the top cell cycle/cell death network enriched in the oocytes from primordial follicles. This is the first report of a gene related to smoking being expressed in oocytes. Nicotine has been shown to dose-dependently impair the folliculogenesis in hamster ovaries by increasing the apoptotic cell death in granulosa cells (Bordel et al., 2006) . Whether the negative effect of smoking on female fecundity and fertility involves the oocyte nicotine receptor CHRNA3 needs further investigations.
The top bio-functions and pathways represented in the MII oocytespecific transcriptome represent very diverse functions reflecting accumulation of transcripts during oocyte development and the many functions that the mature oocyte needs to accomplish to ensure reproductive success. However, the mature oocyte itself appears to undertake no or very low transcriptional activity, in line with the function 'transcription' being enriched in oocytes from the primordial follicle. Low transcriptional activities may partly be ensured by Suppression Of the Cytokine Signaling (SOCS) proteins, since several of the SOCS genes contributed to the observed enrichment of the JAK/STAT signaling in the MII oocyte. The enrichment of the ERK/MAPK pathway and the selectively high expression of MOS in MII oocytes enforce that the MOS-MAPK enzyme system is a critical regulator of the meiotic processes including the resumption of meiosis and cycle arrest upon fertilization (Dupre et al., 2011) . The enrichment of the 'mitotic roles of polo-like kinases' pathway involving the anaphase promoting complex, several cell division cycle proteins (CDC7, CDC20, CDC25), checkpoint CHK2 and the dominant cyclin B (CCNB1) as well as the up-regulation of ESPL1 (separase) and PTTG1 (securin) reveal genes likely to be important in promotion of meiosis, mitosis and cytokinesis upon fertilization. In addition to genes (i.e. GDF9, BMP15 and ZAR1) previously reported as expressed in MII oocytes in other species (Vallee et al., 2005) several genes not previously reported expressed in oocytes were highly expressed in the MII oocyte. One example is the selectively expressed BOD1 (bi-orientation of chromosomes in cell division 1) that encodes a kinetochore protein (Compton, 2007) , suggesting a role in the second meiosis and the subsequent mitosis.
Tumor suppressors and genome protection
Several of the genes highly expressed in the oocyte of the primordial follicle have been reported to be tumor suppressor genes representing both caretakers (repairing damaged genes and holding the cell cycle until repaired) and gatekeepers (inducing apoptosis or senescence).
Of the p53 family of tumor proteins, p63 has been suggested to control the quality and survival of the oocyte pool by involvement in the postpachytene checkpoint and propensity of oocytes to undergo apoptosis (Levine et al., 2011) . In accordance, our data demonstrated that the p63 gene was substantially expressed in human oocytes from the primordial follicle while expression in MII oocytes and somatic cells were very low, confirming previous studies in mice (Suh et al., 2006) .
The transcript encoding the SKI-like oncogene (SkiL/SnoN) protein with vital roles in murine follicle development and inhibition of transforming growth factor beta (TGFb) signaling (Xu et al., 2009) was selectively expressed in oocytes from primordial follicles. In agreement with the TGFb super family members being key regulators of the folliculogenesis and oogenesis (Trombly et al., 2009) , the transcripts of family members BMP15 and GDF9 were absent/very low expressed in oocytes from primordial follicles and both expressed at high levels in MII oocytes. This corresponds to recent findings in mice ovaries showing a gradual decline in SkiL/SnoN expression during folliculogenesis (Tang and Zhang, 2011) , which might be associated with the activation of TGFb leading to SkiL degradation after the primordial follicle stages and subsequently to promote expression of GDF9 and BMP15 mRNA in primary follicles and MII oocytes (McGrath et al., 1995; Aaltonen et al., 1999) .
The reelin (RELN) gene encodes an extracellular glycoprotein involved in neuron migration in both the developing and adult nervous system (Barros et al., 2011) and was moderately but selectively expressed in oocytes from the primordial follicle. Recently, RELN expression has been associated with cancer and suggested to be a possible tumor suppressor (Okamura et al., 2011) . Whether RELN is involved in retaining the follicle in the cell cycle dormant stage remains to be clarified, but a potential effect may act via the pregranulosa cells of the primordial follicle, since the RELN receptor gene (LRP8) has previously been localized in bovine theca and granulosa cells during later stages of the folliculogenesis (Argov and Sklan, 2004) but no data have been reported from the early stages of folliculogenesis or in human.
Another highly up-regulated gene in the oocyte from the primordial follicle is TMEFF2 that is also reported to be a tumor suppressor. The anti-proliferative effect of TMEFF2 has been reported to be regulated by androgens (Gery et al., 2002) and Activin A (Tsai et al., 2010) , both suggested to be involved in the activation of the primordial follicle (McLaughlin and Telfer, 2010) . Future functional studies will show whether TMEFF2 is of importance in keeping the oocyte at the special quiescent cell cycle stage.
To maintain DNA integrity, DNA damage responses coordinate diverse DNA repair and cell cycle checkpoint pathways resulting in cell cycle arrest, DNA repair or apoptosis (Yu and Cortez, 2011) . With regard to the cell cycle checkpoint, the most abundant cyclin in the oocytes from the primordial follicle was cyclin K that was more than 100-fold higher expressed than in the mature oocyte and in the somatic cells, which indicates an important role. The cell cycledependent expression of cyclin K is new (Yu and Cortez, 2011) but it has been shown to be induced by DNA damage agents via a p53-dependent tumor suppressor pathway (Mori et al., 2002) . Experiments in cultured human cells depleted of cyclin K and cyclin-dependent kinase 9 (CDK9), respectively, suggest that CDK9-cyclin K complexes are required for genome maintenance (Yu and Cortez, 2011) . Thus the role of the very high cyclin K expression may be to conserve genome integrity in oocytes from the primordial follicle.
One unique characteristic of DNA in oocytes is the high level of homologous recombination. Human MND1 has been shown to be involved in inducing DNA strand exchange and ensuring the proper synapsis formation of homologous chromosomes in meiosis. An excess amount of the MND1 protein is necessary to obtain stable homologous pairing in meiosis-specific homologous recombination (Pezza et al., 2010 ). The observed high expression level of MND1 in the oocytes from the primordial follicle may be involved in ensuring the stable recombination during the lifespan of the oocytes in the primordial follicle.
Maternal RNAs
Maternal supply of mRNAs to the early embryo is important, as the transition from oocyte to embryo occurs in the absence of transcription (Kronja and Orr-Weaver, 2011 ). Examples of highly enriched transcripts in the MII oocyte are maternal-effect genes such as the factor in the germline alpha (FIGLA), the Zygote Arrest 1 (ZAR1), the maternal embryonic leucine zipper kinase (MELK) and oocyte-expressed protein homolog (OOEP), previously detected in bovine, mouse, and Xenopus laevis MII oocytes (Vallee et al., 2005; Raty et al., 2011) . Previous studies performed on mouse models reveal that deletion of many of these factors are associated with infertility, such as those encoded by FIGLA (Soyal et al., 2000) and ZAR1 (Wu et al., 2003) . The main part of the maternal-effect genes showed a substantial increase in expression in MII oocytes when compared with the oocytes from the primordial follicle. Also the primate specific NLRP11 (NACHT) was extensively expressed in MII oocytes and more than 12-fold higher than in the oocytes from the primordial follicle. Though, other of the NLRP (or NALP) maternal-effect genes as NLRP5 (MATER) mRNA was highly expressed in both developmental oocyte stages as were NLRP2 and NLRP7. The expression of NLRP5 in the oocytes from primordial follicles confirms recent immunostaining data on human fetal ovary (Fowler et al., 2009) .
How oocytes store and subsequently activate mRNA for translation is not well understood. A recent study in mouse oocytes showed that the DCP1 decapping enzyme homolog A (DCP1A), known to be a part of the mRNA processing (P)-bodies in somatic cells (Sheth and Parker, 2003) , re-localize to subcortical aggregates (a novel mRNA storage granules) as the oocyte meiotically matures and the products of the maternal mRNAs are needed (Flemr et al., 2010) . In accordance, the DCP1A transcript was found in the present data to be 35 times higher expressed in the MII oocytes when compared with the oocytes from primordial follicles. Moreover, we also found expression of transcripts encoding several other RNA-binding proteins, such as the DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 (DDX6), the cytoplasmic polyadenylation element-binding protein 1 (CPEB1) and the Y box-binding protein 2 (YBX2) associated with subcortical accumulation as P-body compartments in maturing oocytes (Flemr et al., 2010) . Of these, CPEB1 that modulates poly(A) tail length was highly expressed in MII oocytes, while low expression was found in oocytes from primordial follicles in line with a report on involvement in the post-transcriptional and post-translational regulation during mouse oocyte meiotic maturation (Khan et al., 2005) .
Epigenetics and genetics
In the female germ line, initiation of imprinting occurs after birth during oocyte growth (Lucifero et al., 2004; Hiura et al., 2006; Kota and Feil, 2010) . Many well-known genes associated with epigenetics were expressed in both oocytes from primordial follicle and in MII, such as the DNMT, HDAC, HMT and MBD. DNMT1 that have been reported to be necessary to maintain DNA methylation imprints during maternal to zygotic development in mice (Hirasawa et al., 2008) and the DNMT1 transcript was highly expressed in the MII oocyte. The moderate but selective expression of UHRF2 in MII oocytes may also be of importance for the methylation pattern because UHRF members represent putative regulators of inheritance of the epigenetic code (Pichler et al., 2011) . Another highly and selective MII-expressed transcript potentially related to imprinting is TCL1A, belonging to the proto-oncogene TCL1 family (Noguchi et al., 2007) . TCL1A has not previously been detected in the oocyte, but reported to be expressed in testis (Liu et al., 2010) , where TCL1A was found highly up-regulated in testicular germ cell tumor and categorized as an oncogene as well as a novel stem cell marker (Liu et al., 2010) . A recent study suggested TCL1A to act as an inhibition of de novo DNA methylation (Palamarchuk et al., 2012) . In the oocyte of the primordial follicle, another gene involved in chromatin modeling, the SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin 2 (SMARCA2) mRNA was high, and up to 38-fold higher expressed than observed in the MII oocyte, indicating a role in early oogenesis. The low expression level of SMARCA2 transcripts in human MII oocytes confirms previous observations in murine MII oocytes (Oliveri et al., 2007) and is in line with an increasing methylation of the SMARCA2 gene during progression of oogenesis in the human ovary (Nagrani et al., 2011) .
Insufficient folate intake impairs fertility in animals (Mohanty and Das, 1982) and induces adverse pregnancy outcomes in human (early spontaneous abortions and birth defects) (George et al., 2002) , and a daily periconceptional supplementation is recommended by WHO. The high expression of the FOLR1 in the oocyte from the primordial follicle, The dormant and the fully competent oocyte contrasting the lack of expression in mature oocytes, suggests a function in early folliculogenesis. Folate deficiency has been shown to induce DNA breakage in various cell types in vivo and in vitro as well as cause genomic hypo-methylation in humans and in cells in culture (Crott et al., 2008) . Thus, the high expression of FOLR1 may be involved in protection of the DNA as well as in sustaining appropriate levels of methylation.
Moreover, a recent paper associates FOLR1 genotypes to oocyte fertilization rate, treatment outcome and risk of pregnancy loss in women undergoing IVF treatment connecting FOLR1 to oocyte developmental competence (Sivakumaran et al., 2010) . Regulation of FOLR1 expression in other cell types has recently been shown to be under exquisite control of steroid hormones (Sivakumaran et al., 2010) ; thus the canonical steroid signaling pathways enriched in the oocytes from the primordial follicles may be involved in the regulation of the FOLR1.
A recent publication also links female fertility to genotype, suggesting that blood type O is associated with a reduced ovarian reserve, whereas type A was protective to the reserve independent of advancing age (Nejat et al., 2011) . Interestingly, we observed that ABO was moderately (specific probe set) to highly (less specific probe set) expressed in oocytes from primordial follicles, while low to absent in MII oocytes and granulosa cells, indicating that the ABO gene products, the glycosyltransferases may have a function in the primordial follicle.
Exploring epigenetic mechanisms in germ cell development appears to be important in relation to fertility and human health and the current study has highlighted genes that may be interesting to follow during various manipulations performed in connection with assisted reproduction.
Taken together, the present analysis identified new and known reproduction genes associated with specific stages of human oocyte development including genes centered on cell cycle regulation, DNA protection and epigenetics. The function enrichment analysis added novel genes and suggested molecular mechanisms associated with the unique functions of oocyte in its two extremes of the folliculogenesis. It is indeed intriguing that androgen and estrogen receptor signaling are enriched in the unique transcript profile in the oocyte from the primordial follicle and that several of the highly enriched genes in that oocyte stage such as CDR1, FOLR1 and TMEFF2 expression have been reported to be controlled by steroid hormones in other tissues.
In conclusion, the presented lists of genes being selectively or highly differentially expressed in either of the two developmental extremes of the human oocyte provide an important source for future downstream analysis to further identify genes of significance in human reproduction.
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